Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of hydroxy metabolites of clarithromycin to the pharmacokinetic parameters, and determination of hydroxy metabolites ratio of clarithromycin

  • 76 Accesses

  • 1 Citations

Summary

Clarithromycin is a broad-spectrum macrolide antibacterial agent which is effective bothin vitro andin vivo against the major pathogens responsible for respiratory tract infections. Clarithromycin’s principal metabolite is 14-(R) hydroxyclarithromycin (14-OH-clarithromycin). The other metabolite, namely 14-(S) hydroxyclarithromycin is inactive. The purpose of this study was to show the hydroxylation of CLA at the 14 position to form the R and S epimers and to determine the metabolic ratio of 14ROHCLA/CLA and 14SOHCLA/CLA for understanding the metabolization. This study suggest that in healthy adults, the individual variations in therapeutic responses to clarithromycin can be assumed by taking the drug and its metabolites ratios. Clarithromycin and metabolites ratios increase during metabolization.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Kikuchi E., Yamazaki K., Kikuchi J., et al. (2008): PK of Clarithromycin in bronchial epithelial linig fluid. Respirology, 13, 221–226.

  2. 2.

    Rodrigues D., Roberts E.M., Mulford D.J., et al. (1997), Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Drug Metab. Dispos., 25, 623–630.

  3. 3.

    Honeybourne D., Kees F., Andrews J.M., et al. (1994): The levels of clarithromycin and its 14-hydroxy metabolite in the lung. Eur. Respir J., 7, 1275–1280.

  4. 4.

    Ferrero J.L., Bopp B.A., Marsh K.C., et al. (1990): Metabolism and disposition of clarithromycin in man. Drug Metab. Dispos. 18, 441–446.

  5. 5.

    Jiang Y., Wang J., Li H., et al. (2007): Determination of clarithromycin in human plasma by liquid chromatography-Electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Analysis, 43, 1460–1464.

  6. 6.

    Bebia Z., Buch S.C., Wilson J.W., et al. (2004): Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin. Pharmacol. Ther., 76, 618–627.

Download references

Author information

Correspondence to Durisehvar Unal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Unal, D., Fenercioglu, A., Ozbay, L. et al. The effect of hydroxy metabolites of clarithromycin to the pharmacokinetic parameters, and determination of hydroxy metabolites ratio of clarithromycin. Eur. J. Drug Metabol. Pharmacokinet. 33, 243–246 (2008). https://doi.org/10.1007/BF03190879

Download citation

Keywords

  • Clarithromycin
  • pharmacokinetics
  • hydroxy metabolites
  • humans